Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine Immune-related Adverse Events (irAEs)

Clinical trial NCT05675111 · COMPLETED

Trial details

NCT number: NCT05675111
Sponsor: Nanjing Medical University
Status: COMPLETED
Study type: OBSERVATIONAL

Immune Checkpoint Inhibitor Endocrine Toxicity

Start date: 2018-06-01
Primary completion: 2022-03-31
Enrollment: 12408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.